Spravato (esketamine) for Treatment Resistant Depression - Orlando, Lake Mary, Sanford & Surrounding Areas
Primary Care / Family Medicine, Counseling and
Psychiatry brought together – Whole Person
Healthcare
By targeting the NMDA receptor within nerve cells, SPRAVATO has revolutionized depression treatment. This FDA-approved nasal spray is administered by certified healthcare providers and may reduce symptoms of treatment-resistant depression in hours rather than weeks or months - an unprecedented alternative to typical antidepressants like Fluoxetine (Prozac) and Sertraline (Zoloft). Thousands have already felt relief from this innovative approach with more potential benefits still being explored.
Proven to Reduce Depressive Symptoms
Patients with major depressive disorder and active suicidal thoughts or actions experienced a greater reduction of symptoms when taking SPRAVATO alongside an antidepressant compared to the placebo plus oral antidepressant group after 24 hours. Further reductions were continuously seen throughout four weeks of treatment, demonstrating its potential for lasting effects if patients follow their healthcare provider's recommended plan. While results vary between individuals, this may offer promising hope in treating depression that can last long-term.
SPRAVATO CIII nasal spray must be given under the supervision of a certified healthcare provider at an approved treatment center to ensure safe and responsible use. Before beginning therapy, your doctor will evaluate any potential risks associated with sedation, dissociation, and abuse or misuse.
2 treatments a week for 4 weeks, then
1 treatment a week for 4 weeks, then
Decrease to weekly or every other week to maintain response
Long-term goal – monthly treatment
Spravato shows substantial benefit in many patients within 24 hours, but we request a commitment to the full course of 8 treatments to allow time for the full effects to be seen.
Plan to be in our offices for 2 hours for each treatment and plan to take the remainder of the day off from work, school and other activities. You may not drive the day of the treatment. You will need to plan for a way to get home, such as having a family member or friend take you home.
When overseen by professionals and administered in a controlled clinical setting, Spravato therapy can in fact be a safer alternative to some prescription drugs. Patients should also note that Spravato is not a narcotic and when given in medical setting has not been known to be addictive.
When using Spravato for the treatment of severe depression, you need a psychiatrist who is familiar with your specific condition. Psychiatrists are medical doctors who are specially trained to evaluate and treat illnesses that involve changes in mood, thinking and behavior.
Treating severe depression is a very complex process, and Spravato is known to produce feelings of dissociation or not being real in some patients. Patients with bipolar disorder may become manic. Therefore, we do not recommend that Spravato be given for depression by doctors who are not psychiatrists. A psychiatrist is uniquely able to catch these problems early and intervene. Serious medical side effects are very rare when Spravato is used to treat depression. But just in case, our offices include a medical procedure room.
It’s the first FDA-approved nasal spray specifically for adults with treatment-resistant depression.
If you have unsuccessfully tried two or more antidepressants without relief, contact us today to learn about potential treatments for treatment-resistant depression!
Caya Health - Whole Person Integrated Healthcare
Lake Mary Office Location
1355 S International Pkwy, Unit 1481, Lake Mary, FL. 32746
Appointment Phone Number
Fax Number
All Rights Reserved. Terms and Privacy Policy | Bizimage Marketing